OncoCyte Corp Announces Equity Placement and Fundraising Efforts
Company Announcements

OncoCyte Corp Announces Equity Placement and Fundraising Efforts

OncoCyte Corp (OCX) just unveiled an announcement.

Oncocyte Corporation has initiated a private placement transaction issuing over 5 million common shares and pre-funded warrants to accredited investors, targeting a closing date around April 15, 2024, with expected proceeds of approximately $15.8 million before expenses. These funds are earmarked for general corporate purposes and to redeem outstanding Series A Preferred Stock. The deal includes a registration rights agreement to facilitate the resale of the shares and warrants, and Needham & Company, LLC is serving as the placement agent for this transaction.

See more insights into OCX stock on TipRanks’ Stock Analysis page.

Related Articles
Brian AndersonOCX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
TheFlyOncoCyte files to sell 3.46M shares of common stock for holders
TipRanks Auto-Generated NewsdeskOncoCyte Shareholders Approve Incentive Plan and Meeting Adjournment
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App